Search - tctmd.com

Displaying 61 - 80 of 311

Sort: Relevancy | Date

Presentation THT 2023

Left ventricular reconstruction compared to optimal medical therapy in patients with ischemic cardiomyopathy

Presenter: Oleg Polonetsky

March 21, 2023

Presentation THT 2023

The Role of Guideline Directed Medical Therapy in Functional Improvement after Hybrid Left Ventricular Reconstruction for the Treatment of Ischemic Heart Failure

Presenter: Romy Hegeman

March 21, 2023

Presentation THT 2023

MCS strategies guided by ischemic vs. non-ischemic etiology and HF clinical phenotyping

Presenter: Rachna Kataria

March 21, 2023

Presentation TCT 2022

TCT 348: Evaluating improvement in regional left ventricular function after hybrid minimally invasive left ventricular reconstruction in ischemic cardiomyopathy: CT- or MRI-based inward displacement to overcome current shortcomings in imaging

Presenter: Romy Hegeman

September 18, 2022

Presentation TCT 2022

Influential Trials in High-Risk PCI: Shaping the Future of Ischemic Heart Failure Therapy

Presenter: Jonathan Hill

September 18, 2022

Presentation TCT 2022

TCT 329: Cerebral Embolic Protection Devices For Prevention Of Post-Procedural Ischemic Stroke With Transcatheter Aortic Valve Replacement: A SYSTEMATIC REVIEW AND META-ANALYSIS

Presenter: Tanesh Ayyalu

September 18, 2022

Presentation TCT 2022

TCT 18: De-Escalation of Antiplatelet Therapy in Stabilized Acute Myocardial Infarction Patients with High Ischemic Risk: Post hoc Analysis of TALOS-AMI Trial

Presenter: Donggyu Moon

September 17, 2022

Presentation TCT 2022

Case #3: Symptomatic Microvascular Disease

Presenter: Nils Johnson

September 17, 2022

Presentation TCT 2022

Case #2: MVD With Low Ejection Fraction (High-Risk for CABG)

Presenter: Arnold Seto

September 17, 2022

Presentation TCT 2022

Case #1: Multivessel Coronary Artery Disease

Presenter: Aakriti Gupta

September 17, 2022

Presentation Fellows 2022

The Role of Coronary Revascularization for Stable Ischemic Heart Disease

Presenter: Ajay Kirtane

May 06, 2022

Presentation TCT 2021

Case #1 Resolution: A Patient With High Bleeding and High Ischemic Risk

Presenter: Davide Cao

November 06, 2021

Presentation TCT 2021

Case #1 Introduction: A Patient With High Bleeding and High Ischemic Risk

Presenter: Davide Cao

November 06, 2021

Presentation TCT 2021

DAPT Duration in the Afib Patient: Where Do We Stand?

Presenter: Renato Lopes

November 05, 2021

Presentation TCT 2021

DAPT Duration in High Bleeding Risk Patients: Lessons From RCTs

Presenter: Marco Valgimigli

November 05, 2021

Presentation TCT 2021

DAPT Duration in High Bleeding Risk Patients: Lessons From Registries

Presenter: Davide Cao

November 05, 2021

Presentation TCT 2021

Debate: Follow the Bleeding Risk, Shorten DAPT!

Presenter: Dominick Angiolillo

November 05, 2021

Presentation TCT 2021

Debate: Follow the Ischemic Risk, Prolong DAPT!

Presenter: Robert Yeh

November 05, 2021

Advertisement

Left ventricular reconstruction compared to optimal medical therapy in patients with ischemic cardiomyopathy

The Role of Guideline Directed Medical Therapy in Functional Improvement after Hybrid Left Ventricular Reconstruction for the Treatment of Ischemic Heart Failure

MCS strategies guided by ischemic vs. non-ischemic etiology and HF clinical phenotyping

TCT 348: Evaluating improvement in regional left ventricular function after hybrid minimally invasive left ventricular reconstruction in ischemic cardiomyopathy: CT- or MRI-based inward displacement to overcome current shortcomings in imaging

Influential Trials in High-Risk PCI: Shaping the Future of Ischemic Heart Failure Therapy

TCT 329: Cerebral Embolic Protection Devices For Prevention Of Post-Procedural Ischemic Stroke With Transcatheter Aortic Valve Replacement: A SYSTEMATIC REVIEW AND META-ANALYSIS

TCT 18: De-Escalation of Antiplatelet Therapy in Stabilized Acute Myocardial Infarction Patients with High Ischemic Risk: Post hoc Analysis of TALOS-AMI Trial

Case #3: Symptomatic Microvascular Disease

Case #2: MVD With Low Ejection Fraction (High-Risk for CABG)

Case #1: Multivessel Coronary Artery Disease

The Role of Coronary Revascularization for Stable Ischemic Heart Disease

Case #1 Resolution: A Patient With High Bleeding and High Ischemic Risk

Case #1 Introduction: A Patient With High Bleeding and High Ischemic Risk

DAPT Duration in the Afib Patient: Where Do We Stand?

DAPT Duration in High Bleeding Risk Patients: Lessons From RCTs

DAPT Duration in High Bleeding Risk Patients: Lessons From Registries

Debate: Follow the Bleeding Risk, Shorten DAPT!

Debate: Follow the Ischemic Risk, Prolong DAPT!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content